Because nephrin expression is thought to be a key measure of glomerular function, efforts to conserve it in clinical circumstances like DN show a lot of promise for treating a variety of kidney illnesses in which nephrin loss is a risk factor. The gene discussed is NPHS1; the disease is liver dysplastic nodule.